Medical Education

Cannabis in medicine: where the evidence is strongest

If you want the short answer, the evidence for medical cannabis is strongest in a small number of symptom areas and weaker everywhere else. That is not a slogan. It is the practical shape of the current evidence base.

17 June 2026 2 min read

If you want the short answer, the evidence for medical cannabis is strongest in a small number of symptom areas and weaker everywhere else. That is not a slogan. It is the practical shape of the current evidence base.

For patients, that means the real question is not whether cannabis is "medicinal" in the abstract. The question is whether a particular product, in a particular condition, has enough evidence and enough safety oversight to justify use.

Key takeaways

  • The strongest evidence is in selected pain, spasticity, nausea/vomiting, and some epilepsy-related settings.
  • Side effects are common enough that product choice and dose matter.
  • THC-related effects are often dose-dependent and can be hard to ignore.
  • For many other claims, the evidence is still too thin for confident recommendations.

Evidence base

NICE NG144, NHS guidance, and recent systematic reviews all point in the same direction: some cannabis-based products have a place in narrowly defined clinical situations, but that does not make cannabis a universal treatment. Reviews of medical cannabis products also show that safety is often manageable but not trivial, and that THC is the component most associated with unwanted effects.

In plain English, the evidence is good enough to take certain medical uses seriously, but not good enough to oversell the whole plant. That is why a product-by-product, condition-by-condition approach is the right one.

What patients should know

If you are considering medical cannabis, ask which symptom it is meant to treat, how success will be measured, and what the stop point is if it does not help. Ask whether the product is licensed, who will monitor it, and how side effects will be handled. A vague promise is a warning sign, not a reassurance.

It is also important to remember that not all cannabis products are the same. CBD-heavy products, THC-heavy products, and balanced formulations behave differently. A story about one product should never be treated as proof for all the others.

When to speak to a clinician

  • You want an evidence-based view of whether cannabis fits your condition.
  • You have already tried standard treatment and want to compare options carefully.
  • You are worried about side effects or interactions.
  • You need help understanding the difference between licensed and unlicensed products.
  • You want a symptom goal and a review plan before starting anything new.

Source trail